866-997-4948(US-Canada Toll Free)

United States Drugs of Abuse Testing Market Report 2017

Published By :

QYResearch

Published Date : Jan 2017

Category :

Pharmaceutical

No. of Pages : 104 Pages

This report studies sales (consumption) of Drugs of Abuse Testing in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
F. Hoffmann La-Roche Ltd
Siemens Healthineers (Siemens AG)
Thermo Fisher Scientific, Inc.
Alere, Inc.
Shimadzu Corporation
Laboratory Corporation of America Holdings
Dragerwerk AG & Co. KGaA
Express Diagnostics International Inc.

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of  Drugs of Abuse Testing in each application, can be divided into
Hospitals
Diagnostics Laboratories
On-the-spot Testing
Forensic Laboratories

Table of Contents

1 Drugs of Abuse Testing Overview
1.1 Product Overview and Scope of Drugs of Abuse Testing
1.2 Classification of Drugs of Abuse Testing
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Drugs of Abuse Testing
1.3.1 Hospitals
1.3.2 Diagnostics Laboratories
1.3.3 On-the-spot Testing
1.3.4 Forensic Laboratories
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Drugs of Abuse Testing (2011-2021)
1.4.1 United States Drugs of Abuse Testing Sales and Growth Rate (2011-2021)
1.4.2 United States Drugs of Abuse Testing Revenue and Growth Rate (2011-2021)

2 United States Drugs of Abuse Testing Competition by Manufacturers
2.1 United States Drugs of Abuse Testing Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Drugs of Abuse Testing Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Drugs of Abuse Testing Average Price by Manufactures (2015 and 2016)
2.4 Drugs of Abuse Testing Market Competitive Situation and Trends
2.4.1 Drugs of Abuse Testing Market Concentration Rate
2.4.2 Drugs of Abuse Testing Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Drugs of Abuse Testing Sales (Volume) and Revenue (Value) by States (2011-2016)
3.1 United States Drugs of Abuse Testing Sales and Market Share by States (2011-2016)
3.2 United States Drugs of Abuse Testing Revenue and Market Share by States (2011-2016)
3.3 United States Drugs of Abuse Testing Price by States (2011-2016)

4 United States Drugs of Abuse Testing Sales (Volume) and Revenue (Value) by Type (2011-2016)
4.1 United States Drugs of Abuse Testing Sales and Market Share by Type (2011-2016)
4.2 United States Drugs of Abuse Testing Revenue and Market Share by Type (2011-2016)
4.3 United States Drugs of Abuse Testing Price by Type (2011-2016)
4.4 United States Drugs of Abuse Testing Sales Growth Rate by Type (2011-2016)

5 United States Drugs of Abuse Testing Sales (Volume) by Application (2011-2016)
5.1 United States Drugs of Abuse Testing Sales and Market Share by Application (2011-2016)
5.2 United States Drugs of Abuse Testing Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 United States Drugs of Abuse Testing Manufacturers Profiles/Analysis
6.1 F. Hoffmann La-Roche Ltd
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Drugs of Abuse Testing Product Type, Application and Specification
6.1.2.1 Type I
6.1.2.2 Type II
6.1.3 F. Hoffmann La-Roche Ltd Drugs of Abuse Testing Sales, Revenue, Price and Gross Margin (2011-2016)
6.1.4 Main Business/Business Overview
6.2 Siemens Healthineers (Siemens AG)
6.2.2 Drugs of Abuse Testing Product Type, Application and Specification
6.2.2.1 Type I
6.2.2.2 Type II
6.2.3 Siemens Healthineers (Siemens AG) Drugs of Abuse Testing Sales, Revenue, Price and Gross Margin (2011-2016)
6.2.4 Main Business/Business Overview
6.3 Thermo Fisher Scientific, Inc.
6.3.2 Drugs of Abuse Testing Product Type, Application and Specification
6.3.2.1 Type I
6.3.2.2 Type II
6.3.3 Thermo Fisher Scientific, Inc. Drugs of Abuse Testing Sales, Revenue, Price and Gross Margin (2011-2016)
6.3.4 Main Business/Business Overview
6.4 Alere, Inc.
6.4.2 Drugs of Abuse Testing Product Type, Application and Specification
6.4.2.1 Type I
6.4.2.2 Type II
6.4.3 Alere, Inc. Drugs of Abuse Testing Sales, Revenue, Price and Gross Margin (2011-2016)
6.4.4 Main Business/Business Overview
6.5 Shimadzu Corporation
6.5.2 Drugs of Abuse Testing Product Type, Application and Specification
6.5.2.1 Type I
6.5.2.2 Type II
6.5.3 Shimadzu Corporation Drugs of Abuse Testing Sales, Revenue, Price and Gross Margin (2011-2016)
6.5.4 Main Business/Business Overview
6.6 Laboratory Corporation of America Holdings
6.6.2 Drugs of Abuse Testing Product Type, Application and Specification
6.6.2.1 Type I
6.6.2.2 Type II
6.6.3 Laboratory Corporation of America Holdings Drugs of Abuse Testing Sales, Revenue, Price and Gross Margin (2011-2016)
6.6.4 Main Business/Business Overview
6.7 Dragerwerk AG & Co. KGaA
6.7.2 Drugs of Abuse Testing Product Type, Application and Specification
6.7.2.1 Type I
6.7.2.2 Type II
6.7.3 Dragerwerk AG & Co. KGaA Drugs of Abuse Testing Sales, Revenue, Price and Gross Margin (2011-2016)
6.7.4 Main Business/Business Overview
6.8 Express Diagnostics International Inc.
6.8.2 Drugs of Abuse Testing Product Type, Application and Specification
6.8.2.1 Type I
6.8.2.2 Type II
6.8.3 Express Diagnostics International Inc. Drugs of Abuse Testing Sales, Revenue, Price and Gross Margin (2011-2016)
6.8.4 Main Business/Business Overview

7 Drugs of Abuse Testing Manufacturing Cost Analysis
7.1 Drugs of Abuse Testing Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Drugs of Abuse Testing

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Drugs of Abuse Testing Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Drugs of Abuse Testing Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Drugs of Abuse Testing Market Forecast (2016-2021)
11.1 United States Drugs of Abuse Testing Sales, Revenue Forecast (2016-2021)
11.2 United States Drugs of Abuse Testing Sales Forecast by Type (2016-2021)
11.3 United States Drugs of Abuse Testing Sales Forecast by Application (2016-2021)
11.4 Drugs of Abuse Testing Price Forecast (2016-2021)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

Figure Picture of Drugs of Abuse Testing
Table Classification of Drugs of Abuse Testing
Figure United States Sales Market Share of Drugs of Abuse Testing by Type in 2015
Figure Type I Picture
Figure Type II Picture
Figure Type III Picture
Table Application of Drugs of Abuse Testing
Figure United States Sales Market Share of Drugs of Abuse Testing by Application in 2015
Figure Hospitals Examples
Figure Diagnostics Laboratories Examples
Figure On-the-spot Testing Examples
Figure Forensic Laboratories Examples
Figure United States Drugs of Abuse Testing Sales and Growth Rate (2011-2021)
Figure United States Drugs of Abuse Testing Revenue and Growth Rate (2011-2021)
Table United States Drugs of Abuse Testing Sales of Key Manufacturers (2015 and 2016)
Table United States Drugs of Abuse Testing Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs of Abuse Testing Sales Share by Manufacturers
Figure 2016 Drugs of Abuse Testing Sales Share by Manufacturers
Table United States Drugs of Abuse Testing Revenue by Manufacturers (2015 and 2016)
Table United States Drugs of Abuse Testing Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Drugs of Abuse Testing Revenue Share by Manufacturers
Table 2016 United States Drugs of Abuse Testing Revenue Share by Manufacturers
Table United States Market Drugs of Abuse Testing Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Drugs of Abuse Testing Average Price of Key Manufacturers in 2015
Figure Drugs of Abuse Testing Market Share of Top 3 Manufacturers
Figure Drugs of Abuse Testing Market Share of Top 5 Manufacturers
Table United States Drugs of Abuse Testing Sales by States (2011-2016)
Table United States Drugs of Abuse Testing Sales Share by States (2011-2016)
Figure United States Drugs of Abuse Testing Sales Market Share by States in 2015
Table United States Drugs of Abuse Testing Revenue and Market Share by States (2011-2016)
Table United States Drugs of Abuse Testing Revenue Share by States (2011-2016)
Figure Revenue Market Share of Drugs of Abuse Testing by States (2011-2016)
Table United States Drugs of Abuse Testing Price by States (2011-2016)
Table United States Drugs of Abuse Testing Sales by Type (2011-2016)
Table United States Drugs of Abuse Testing Sales Share by Type (2011-2016)
Figure United States Drugs of Abuse Testing Sales Market Share by Type in 2015
Table United States Drugs of Abuse Testing Revenue and Market Share by Type (2011-2016)
Table United States Drugs of Abuse Testing Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Drugs of Abuse Testing by Type (2011-2016)
Table United States Drugs of Abuse Testing Price by Type (2011-2016)
Figure United States Drugs of Abuse Testing Sales Growth Rate by Type (2011-2016)
Table United States Drugs of Abuse Testing Sales by Application (2011-2016)
Table United States Drugs of Abuse Testing Sales Market Share by Application (2011-2016)
Figure United States Drugs of Abuse Testing Sales Market Share by Application in 2015
Table United States Drugs of Abuse Testing Sales Growth Rate by Application (2011-2016)
Figure United States Drugs of Abuse Testing Sales Growth Rate by Application (2011-2016)
Table F. Hoffmann La-Roche Ltd Basic Information List
Table F. Hoffmann La-Roche Ltd Drugs of Abuse Testing Sales, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann La-Roche Ltd Drugs of Abuse Testing Sales Market Share (2011-2016)
Table Siemens Healthineers (Siemens AG) Basic Information List
Table Siemens Healthineers (Siemens AG) Drugs of Abuse Testing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Siemens Healthineers (Siemens AG) Drugs of Abuse Testing Sales Market Share (2011-2016)
Table Thermo Fisher Scientific, Inc. Basic Information List
Table Thermo Fisher Scientific, Inc. Drugs of Abuse Testing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Thermo Fisher Scientific, Inc. Drugs of Abuse Testing Sales Market Share (2011-2016)
Table Alere, Inc. Basic Information List
Table Alere, Inc. Drugs of Abuse Testing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alere, Inc. Drugs of Abuse Testing Sales Market Share (2011-2016)
Table Shimadzu Corporation Basic Information List
Table Shimadzu Corporation Drugs of Abuse Testing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shimadzu Corporation Drugs of Abuse Testing Sales Market Share (2011-2016)
Table Laboratory Corporation of America Holdings Basic Information List
Table Laboratory Corporation of America Holdings Drugs of Abuse Testing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Laboratory Corporation of America Holdings Drugs of Abuse Testing Sales Market Share (2011-2016)
Table Dragerwerk AG & Co. KGaA Basic Information List
Table Dragerwerk AG & Co. KGaA Drugs of Abuse Testing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dragerwerk AG & Co. KGaA Drugs of Abuse Testing Sales Market Share (2011-2016)
Table Express Diagnostics International Inc. Basic Information List
Table Express Diagnostics International Inc. Drugs of Abuse Testing Sales, Revenue, Price and Gross Margin (2011-2016)
Table Express Diagnostics International Inc. Drugs of Abuse Testing Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs of Abuse Testing
Figure Manufacturing Process Analysis of Drugs of Abuse Testing
Figure Drugs of Abuse Testing Industrial Chain Analysis
Table Raw Materials Sources of Drugs of Abuse Testing Major Manufacturers in 2015
Table Major Buyers of Drugs of Abuse Testing
Table Distributors/Traders List
Figure United States Drugs of Abuse Testing Production and Growth Rate Forecast (2016-2021)
Figure United States Drugs of Abuse Testing Revenue and Growth Rate Forecast (2016-2021)
Table United States Drugs of Abuse Testing Production Forecast by Type (2016-2021)
Table United States Drugs of Abuse Testing Consumption Forecast by Application (2016-2021)
Table United States Drugs of Abuse Testing Sales Forecast by States (2016-2021)
Table United States Drugs of Abuse Testing Sales Share Forecast by States (2016-2021)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *